All Stories

  1. Evidence-Based Medical Therapy for Mitral Regurgitation in Dogs
  2. Development of a Time-based Drug Screening Platform for Improved Clinical Translation
  3. A Roadmap for the Future of Systems Biology in Cancer Research
  4. Retrospective Evaluation of Treatment and Survival of Blunt Trauma‐Associated Pneumothorax in Dogs: 89 Cases (2018–2022)
  5. Retrospective Evaluation of the Incidence and Risk Factors Associated With the Development of a Hepatopathy in Xylitol Ingestion: 95 Dogs (2018–2022)
  6. Interdisciplinary research seeks treatments and cures for diseases of animals and humans
  7. Establishing a Canine Urothelial Organoid Repository: A Platform for Comparative and Translational Carcinoma Studies
  8. Innovative In Vitro-In Silico Platform for Dose-Response Modeling in Canine Bladder Cancer: A 3D Organoid- and Mathematics-Based Approach
  9. Letter Regarding “Recommendations for a Complete Reporting of Statistical Methods in Veterinary Pharmacology”
  10. Optimizing First‐Line Therapeutics in Non‐Small Cell Lung Cancer: Insights From Joint Modeling and Large‐Scale Data Analysis
  11. Evolving value and validity of animal models in veterinary therapeutic research: Impact of scientific progress
  12. Restorative Effects of Synbiotics on Colonic Ultrastructure and Oxidative Stress in Dogs with Chronic Enteropathy
  13. OrganoidChip+: a Microfluidic Platform for Culturing, Staining, Immobilization, and High-Content Imaging of Adult Stem Cell-Derived Organoids
  14. Penicillin and Gentamicin Concentrations in the Uterine Fluid of Non‐Pregnant Mares Following a Single Intrauterine Infusion
  15. Frequency and Characterization of Rare Histologic Subtypes in Canine Invasive Urothelial Carcinoma
  16. Incidence of hypernatremia in dogs treated with multi-dose activated charcoal for acute toxicant ingestion: multi-center retrospective study (2018–2023)
  17. <span style="mso-bidi-font-weight: bold;">Spontaneous Canine Disease Models in Biomedical Science: A One Health Path to Predictive Drug Development
  18. Development and Characterization of Chicken Lung Organoids for Future In Vitro Modeling of Avian Influenza Virus-Host Cell Interaction
  19. A Preclinical Model to Assess Intestinal Barrier Integrity Using Canine Enteroids and Colonoids
  20. The association between non-depolarizing neuromuscular blockade agents and survival to discharge in dogs undergoing mechanical ventilation: a multi-center retrospective study of 227 dogs (2010–2020)
  21. Retrospective Evaluation of Complications Associated With Surgically Placed Gastrostomy Tubes in Dogs (2010–2020): 133 Cases
  22. Effects of a Western Diet on Colonic Dysbiosis, Bile Acid Dysmetabolism and Intestinal Inflammation in Clinically Healthy Dogs
  23. Incidence of hypernatremia in dogs treated with single dose activated charcoal for acute toxicant ingestion: multi-center retrospective study (2018–2023)
  24. A Novel Preclinical Model to Assess Intestinal Barrier Integrity Using Canine Enteroids and Colonoids
  25. A multi-stage feature selection method to improve classification of potential super-agers and cognitive decliners using structural brain MRI data—a UK biobank study
  26. Utilization of peripheral glucose and lactate differences in the diagnosis of feline arterial thromboembolism: a multi-center study
  27. Dose‐exposure‐response of CARDALIS® (benazepril/spironolactone) on the classical and alternative arms of the renin‐angiotensin‐aldosterone system in healthy dogs
  28. Frequency and progression of azotemia during acute and chronic treatment of congestive heart failure in cats
  29. Treatment of Canine Myxomatous Mitral Valve Disease:Current and Future Approaches
  30. University of Georgia College of Veterinary Medicine’s Precision One Health Initiative improves animal and human health by developing alternative models of disease
  31. Cisplatin-Induced Metabolic Responses Measured with Raman Spectroscopy in Cancer Cells, Spheroids, and Canine-Derived Organoids
  32. Preclinical modeling of metabolic syndrome to study the pleiotropic effects of novel antidiabetic therapy independent of obesity
  33. 166 Development of non-model organoids in animal research: A paradigm shift in in vitro models
  34. Pharmacokinetics of isavuconazonium sulfate and its active metabolite isavuconazole in healthy dogs
  35. Evaluating the Bias of Two Point-of-Care Glucometers for Calves and Ewes: Awareness for Ruminant Practitioners
  36. Systemic absorption and gastrointestinal adverse effects from topical ketorolac and diclofenac ophthalmic solutions in healthy dogs
  37. Renin-Angiotensin Aldosterone System Modulation and Cardiovascular-Kidney-Metabolic Health
  38. Population Pharmacokinetics and Absolute Oral Bioavailability of Lasalocid after Single Intravenous and Intracrop Administration in Laying Hens
  39. Abstract PR002: Sarcomatoid Histological Variants of Canine Muscle-Invasive Bladder Cancer: Transcription Factor Activation Highlights Pathways of Epithelial-Mesenchymal Transformation Similar to Humans
  40. Retrospective evaluation of the prevalence and risk factors associated with red blood cell transfusions in cats with urethral obstruction (2009–2019): 575 cases
  41. Randomized comparison between a forced air system and warm water bath for resuscitation of neonatal hypothermic calves with or without oral administration of caffeine
  42. Preclinical Modeling of Metabolic Syndrome to Study the Pleiotropic Effects of Novel Antidiabetic Therapy Independent of Obesity
  43. Experimental Methods for Establishing and Maintaining Canine Bladder Cancer Organoids
  44. A machine learning approach for potential Super‐Agers identification using neuronal functional connectivity networks
  45. Evaluation of different media compositions promoting hepatocyte differentiation in the canine liver organoid model
  46. Letter regarding “Fuzapladib in a randomized controlled multicenter masked study in dogs with presumptive acute onset pancreatitis”
  47. Comparison of Traditional Didactic Versus Additional Hands-On Simulation Training in the Performance of Basic Life Support in Veterinary Students—A Prospective, Blinded, Randomized Study
  48. Comprehensive characterization of the effect of mineralocorticoid receptor antagonism with spironolactone on the renin-angiotensin-aldosterone system in healthy dogs
  49. Establishment and characterization of turtle liver organoids provides a potential model to decode their unique adaptations
  50. Effect of amlodipine on the circulating renin‐angiotensin‐aldosterone system in healthy cats
  51. Genetic Factors of Alzheimer’s Disease Modulate How Diet is Associated with Long-Term Cognitive Trajectories: A UK Biobank Study
  52. Adult Animal Stem Cell-Derived Organoids in Biomedical Research and the One Health Paradigm
  53. Leveraging the predictive power of 3D organoids in dogs to develop new treatments for man and man’s best friend
  54. A Preclinical Model of Obesity-Independent Metabolic Syndrome for Studying the Effects of Novel Antidiabetic Therapy Beyond Glycemic Control
  55. Retrospective evaluation of admission total plasma protein as a predictor of red blood cell transfusion requirement in dogs diagnosed with traumatic and nontraumatic hemoabdomen: 90 dogs (2009–2019)
  56. Exploring the benefits of in-diet versus repeated oral dosing of saracatinib (AZD0530) in chronic studies: insights into pharmacokinetics and animal welfare
  57. A Preclinical Model of Obesity-Independent Metabolic Syndrome for Studying the Effects of Novel Antidiabetic Therapy Beyond Glycemic Control
  58. Exploring the Potential Links Between Gut Bacteria-Related Metabolites and the Risk of Cardiovascular Diseases
  59. Role of the tumour microenvironment in bladder cancer pathogenesis and value of the reverse translational approach: a tale of two species
  60. Effect of the Probiotic Bacillus subtilis DE-CA9TM on Fecal Scores, Serum Oxidative Stress Markers and Fecal and Serum Metabolome in Healthy Dogs
  61. Retrospective comparison of outcomes in septic peritonitis with or without closed-suction abdominal drainage in 115 dogs (2009–2019)
  62. Phenylbutazone concentrations in synovial fluid following administration via intravenous regional limb perfusion in the forelimbs of six adult horses
  63. Gene Editing and Gene Therapy in Oncology
  64. Echocardiographic caudal vena cava measurements in healthy cats and in cats with congestive heart failure and non-cardiac causes of cavitary effusions
  65. Blood product usage and factors associated with transfusions in cats with hemoperitoneum: 33 cases (2018–2022)
  66. OrganoidChip facilitates hydrogel-free immobilization for fast and blur-free imaging of organoids
  67. Changes of Enterocyte Morphology and Enterocyte: Goblet Cell Ratios in Dogs with Protein-Losing and Non-Protein-Losing Chronic Enteropathies
  68. Increased drug concentration and repeated eye drop administration as strategies to optimize topical drug delivery: A fluorophotometric study in healthy dogs
  69. O62 | Population pharmacokinetics of sodium salicylate in chickens and turkeys – New insights into the drug's non‐linear elimination
  70. O89 | A novel biologically relevant canine in vitro model for the study of intestinal inflammation
  71. O59 | Breakthrough: A first‐in‐class virtual simulator for dose optimization of ACE inhibitors in veterinary cardiology
  72. O60 | Comparison of intestinal barrier integrity in conventional 2D cell lines and canine duodenal enteroids
  73. P51 | Evaluation of potential anti‐inflammatory and barrier‐enhancing effects of indoles on the canine duodenum using intestinal organoids
  74. O90 | Lung organoids as a novel model to study the pathogenesis of swine respiratory diseases
  75. O88 | Prediction of treatment response using canine urine‐derived bladder cancer organoids
  76. O63 | Population pharmacokinetics and absolute oral bioavailability of lasalocid ionophore in laying hens
  77. Leveraging Data from Spontaneous Animal Disease Models to Streamline Pharmaceutical Research: A Tale of Two Species
  78. Comprehensive characterization of the effect of mineralocorticoid receptor antagonism with spironolactone on the renin-angiotensin-aldosterone system in healthy dogs.
  79. Canine Intestinal Organoids as a Novel In Vitro Model of Intestinal Drug Permeability: A Proof-of-Concept Study
  80. Canine Intestinal Organoids as a Novel In Vitro Model of Intestinal Drug Permeability: A Proof-of-Concept Study
  81. Exploring the secrets of super-aging: a UK Biobank study on brain health and cognitive function
  82. Understanding the background and clinical significance of the WHO, WOAH, and EMA classifications of antimicrobials to mitigate antimicrobial resistance
  83. Pharmacokinetics of intramuscular maropitant in pigs (Sus scrofa domesticus)
  84. Breakthrough: a first-in-class virtual simulator for dose optimization of ACE inhibitors in translational cardiovascular medicine
  85. Characterization of the First Turtle Organoids: A Model for Investigating Unique Adaptations with Biomedical Potential
  86. Dose–response of benazepril on biomarkers of the classical and alternative pathways of the renin–angiotensin–aldosterone system in dogs
  87. Retrospective evaluation of the effect of inhalant anesthesia on complications and recurrence rates in feline urethral obstruction
  88. Pharmacokinetic and pharmacodynamic properties of pantoprazole in calves
  89. Ionophore coccidiostats – disposition kinetics in laying hens and residues transfer to eggs
  90. Joint Modeling of First-Line Therapeutics in Non-Small Cell Lung Cancer Using Large Database Reveals Potential Benefits of Scheduling Optimization
  91. Retrospective Comparison of Outcomes in Septic Peritonitis With or Without Closed-Suction Abdominal Drainage in 115 Dogs (2009-2019)
  92. Synbiotic-IgY Therapy Modulates the Mucosal Microbiome and Inflammatory Indices in Dogs with Chronic Inflammatory Enteropathy: A Randomized, Double-Blind, Placebo-Controlled Study
  93. Pilot safety evaluation of doxorubicin chemotherapy combined with non-specific immunotherapy (Immunocidin®) for canine splenic hemangiosarcoma
  94. Comparison of the pharmacokinetics of continuous and intermittent infusions of ampicillin-sulbactam in dogs with septic peritonitis
  95. Breakthrough: A First-In-Class Virtual Simulator for Dose Optimization of ACE Inhibitors in Translational Cardiovascular Medicine
  96. Breakthrough: A First-In-Class Virtual Simulator for Dose Optimization of ACE Inhibitors in Veterinary Cardiology
  97. Linear external skeletal fixation applied in minimally invasive fashion for stabilization of nonarticular tibial fractures in dogs and cats
  98. Culture and characterization of canine and feline corneal epithelial organoids: A new tool for the study and treatment of corneal diseases
  99. Retrospective evaluation of risk factors for development of kidney injury after parenteral furosemide treatment of left‐sided congestive heart failure in dogs
  100. Kinetics and minimal inhibitory concentrations of ceftiofur in tear film following extended-release parenteral administration (Excede®) in dogs
  101. Bioenergetic and vascular predictors of potential super-ager and cognitive decline trajectories—a UK Biobank Random Forest classification study
  102. Ketogenic diets in healthy dogs induce gut and serum metabolome changes suggestive of anti‐tumourigenic effects: A model for human ketotherapy trials
  103. Dose-response of benazepril on biomarkers of the classical and alternative pathways of the renin-angiotensin-aldosterone system in dogs
  104. Differential Transcriptomic Profiles Following Stimulation with Lipopolysaccharide in Intestinal Organoids from Dogs with Inflammatory Bowel Disease and Intestinal Mast Cell Tumor
  105. A Multi-Tissue Comparison and Molecular Characterization of Canine Organoids
  106. Letter regarding “Gastrointestinal foreign bodies in pet pigs: 17 cases”
  107. Retrospective Evaluation of Clinical Bleeding in Dogs With Anticoagulant Rodenticide Toxicity—A Multi-Center Evaluation of 62 Cases (2010–2020)
  108. Pharmacokinetic Exposures Associated With Oral Administration of Sorafenib in Dogs With Spontaneous Tumors
  109. Using machine learning to predict COVID-19 infection and severity risk among 4510 aged adults: a UK Biobank cohort study
  110. SGLT2 Inhibitors and Potential Applications in Treating Metabolic Syndrome
  111. Comparisons of plasma and fecal pharmacokinetics of danofloxacin and enrofloxacin in healthy and Mannheimia haemolytica infected calves
  112. Circulating renin‐angiotensin‐aldosterone system activity in cats with systemic hypertension or cardiomyopathy
  113. Canine Intestinal Organoids in a Dual-Chamber Permeable Support System
  114. Standardization and Maintenance of 3D Canine Hepatic and Intestinal Organoid Cultures for Use in Biomedical Research
  115. Differential Transcriptomic Profiles in Canine Intestinal Organoids Following Lipopolysaccharide Stimulation
  116. Suspected primary hyperreninism in a cat with malignant renal sarcoma and global renin‐angiotensin‐aldosterone system upregulation
  117. Multiomic analysis defines the first microRNA atlas across all small intestinal epithelial lineages and reveals novel markers of almost all major cell types
  118. Albumin in Tears Modulates Bacterial Susceptibility to Topical Antibiotics in Ophthalmology
  119. Harnessing the Biology of Canine Intestinal Organoids to Heighten Understanding of Inflammatory Bowel Disease Pathogenesis and Accelerate Drug Discovery: A One Health Approach
  120. Current diagnostics for chronic enteropathies in dogs
  121. Clinical efficacy of prebiotics and glycosaminoglycans versus placebo In dogs with food responsive enteropathy receiving a hydrolyzed diet: A pilot study
  122. Pharmacokinetics of Pantoprazole and Pantoprazole Sulfone in Goats After Intravenous Administration: A Preliminary Report
  123. Pharmacokinetics of tulathromycin in pregnant ewes (Ovis aries) challenged with Campylobacter jejuni
  124. CULTURE AND MAINTENANCE OF URINE-DERIVED, 3-DIMENSIONAL CANINE TRANSITIONAL CELL CARCINOMA ORGANOIDS
  125. Retrospective evaluation of a dose‐dependent effect of angiotensin‐converting enzyme inhibitors on long‐term outcome in dogs with cardiac disease
  126. Computed tomography evaluation of proposed implant corridors in canine thoracic vertebrae
  127. Inflammation, negative affect, and amyloid burden in Alzheimer’s disease: Insights from the kynurenine pathway
  128. Focused ultrasound of the caudal vena cava in dogs with cavitary effusions or congestive heart failure: A prospective, observational study
  129. Corrigendum: Comparative Pharmacokinetics of Meloxicam Between Healthy Post-partum vs. Mid-lactation Dairy Cattle
  130. Gene Editing and Gene Therapy: Entering Uncharted Territory in Veterinary Oncology
  131. Radiation exposure associated with percutaneous fluoroscopically guided lag screw fixation for sacroiliac luxation in dogs
  132. Short‐term outcomes of 59 dogs treated for ilial body fractures with locking or non‐locking plates
  133. Comparison of Canine and Human Physiological Factors: Understanding Interspecies Differences that Impact Drug Pharmacokinetics
  134. Clinical Efficacy of Prebiotics and Glycosaminoglycans versus Placebo In Dogs with Food Responsive Enteropathy Receiving a Hydrolyzed Diet: A Pilot Study
  135. Effect of prazosin on feline recurrent urethral obstruction
  136. Presentation, Clinical Pathology Abnormalities, and Identification of Gastrointestinal Parasites in Camels (Camelus bactrianus and Camelus dromedarius) Presenting to Two North American Veterinary Teaching Hospitals. A Retrospective Study: 1980–2020
  137. Influence of Schirmer strip wetness on volume absorbed, volume recovered, and total protein content in canine tears
  138. A Multi-Institutional Retrospective Analysis of Toceranib Phosphate for Presumed or Confirmed Canine Aortic Body Chemodectomas
  139. Letter to the editor regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
  140. Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s Treasure
  141. Comprehensive Joint Modeling of First-Line Therapeutics in Non-Small Cell Lung Cancer
  142. Pharmacokinetics and Tissue Levels of Pantoprazole in Neonatal Calves After Intravenous Administration
  143. Genetic Factors of Alzheimer’s Disease Modulate How Diet is Associated with Long-Term Cognitive Trajectories: A UK Biobank Study
  144. Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash is Another Man’s Treasure
  145. Genetics and Immunopathogenesis of Chronic Inflammatory Enteropathies in Dogs
  146. Impact of diurnal variation, sex, tear collection method, and disease state on tear protein levels in dogs
  147. Tear Film Pharmacokinetics and Systemic Absorption Following Topical Administration of 1% Prednisolone Acetate Ophthalmic Suspension in Dogs
  148. Pharmacokinetics of Oral Prednisone at Various Doses in Dogs: Preliminary Findings Using a Naïve Pooled-Data Approach
  149. Considerations in the extrapolation of drug toxicity between humans and dogs
  150. Evaluation of a Pasteurella multocida Respiratory Disease Induction Model for Goats (Capra aegagrus hircus)
  151. Non-Linear Mixed-Effects Pharmacokinetic Modeling of the Novel COX-2 Selective Inhibitor Vitacoxib in Cats
  152. Serum albumin and total protein concentration in the tear film of horses with healthy or diseased eyes
  153. Comparative Pharmacokinetics of Meloxicam Between Healthy Post-partum vs. Mid-lactation Dairy Cattle
  154. Pharmacokinetics of Intravenous, Intramuscular, Oral, and Transdermal Administration of Flunixin Meglumine in Pre-wean Piglets
  155. Neuroinflammation, Depressive Affect, and Amyloid Burden in Alzheimer’s Disease: Insights from the Kynurenine Pathway
  156. Effects of the estrous cycle and pregnancy status on cardiovascular variables in healthy bitches
  157. An eye on the dog as the scientist's best friend for translational research in ophthalmology: Focus on the ocular surface
  158. Treatment With Hydrolyzed Diet Supplemented With Prebiotics and Glycosaminoglycans Alters Lipid Metabolism in Canine Inflammatory Bowel Disease
  159. Impact of acute conjunctivitis on ocular surface homeostasis in dogs
  160. Walking in the Light: How History of Physical Activity, Sunlight, and Vitamin D Account for Body Fat—A UK Biobank Study
  161. An Eye on the Dog as the Scientist’s Best Friend for Translational Research in Ophthalmology: Focus on the Ocular Surface
  162. Recapitulation of the accessible interface of biopsy-derived canine intestinal organoids to study epithelial-luminal interactions
  163. Evaluation of dose-response effects of short-term oral prednisone administration on clinicopathologic and hemodynamic variables in healthy dogs
  164. Harnessing The Biology of Intestinal Organoids To Accelerate Drug Discovery in Inflammatory Bowel Disease: A One Health Approach
  165. Serum Vitamin B12, and Related MTRR and Cubilin Genotypes, Predict Neural Outcomes across the AD Spectrum
  166. A Retrospective Clinical Investigation of the Safety and Adverse Effects of Pantoprazole in Hospitalized Ruminants
  167. Investigation of Schirmer tear test-1 for measurement of tear production in cats in various environmental settings and with different test durations
  168. Population modeling of tumor growth curves and the reduced Gompertz model improve prediction of the age of experimental tumors
  169. Apparent total tract digestibility, fecal characteristics, and blood parameters of healthy adult dogs fed high-fat diets
  170. Albumin Levels in Tear Film Modulate the Bioavailability of Medically-Relevant Topical Drugs
  171. CSF glucose tracks regional tau progression based on Alzheimer's disease risk factors
  172. Glucocorticoid and dietary effects on mucosal microbiota in canine inflammatory bowel disease
  173. Kinetics of Fluorescein in Tear Film After Eye Drop Instillation in Beagle Dogs: Does Size Really Matter?
  174. Nerve growth factor in dogs: Assessment of two immunoassays and selected ocular parameters following a nicergoline challenge per os
  175. In vitro Cytotoxicity and Pharmacokinetic Evaluation of Pharmacological Ascorbate in Dogs
  176. Aging-related changes in fluid intelligence, muscle and adipose mass, and sex-specific immunologic mediation: A longitudinal UK Biobank study
  177. Re: “Evaluation of Enrofloxacin for Use in Cryopreservation of Zebu Bull (Bos indicus) Semen” by Ishaq et al. (Biopreserv Biobank 2019;[Epub ahead of print]; DOI: 10.1089/bio.2018.0133)
  178. Pharmacokinetic Modeling of Ceftiofur Sodium Using Non-linear Mixed-Effects in Healthy Beagle Dogs
  179. Fluorophotometric Assessment of Tear Volume and Turnover Rate in Healthy Dogs and Cats
  180. Clinicopathologic, hemodynamic, and echocardiographic effects of short-term oral administration of anti-inflammatory doses of prednisolone to systemically normal cats
  181. Nonlinear mixed‐effects pharmacokinetic modeling of the novel COX‐2 selective inhibitor vitacoxib in dogs
  182. Pharmacokinetic Modeling of Ceftiofur Sodium Using Nonlinear Mixed-Effects in Healthy Beagle Dogs
  183. Histamine-Induced Conjunctivitis and Breakdown of Blood–Tear Barrier in Dogs: A Model for Ocular Pharmacology and Therapeutics
  184. Microbiota-Related Changes in Unconjugated Fecal Bile Acids Are Associated With Naturally Occurring, Insulin-Dependent Diabetes Mellitus in Dogs
  185. The Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review
  186. A reduced Gompertz model for predicting tumor age using a population approach
  187. Effects of experimentally induced respiratory disease on the pharmacokinetics and tissue residues of tulathromycin in meat goats
  188. Indoleamine-pyrrole 2,3-dioxygenase-1 (IDO-1) mRNA is over-expressed in the duodenal mucosa and is negatively correlated with serum tryptophan concentrations in dogs with protein-losing enteropathy
  189. Interleukin‐13 and interleukin‐33 mRNA are underexpressed in the duodenal mucosa of German Shepherd dogs with chronic enteropathy
  190. Paper spray high-resolution accurate mass spectrometry for quantitation of voriconazole in equine tears
  191. Tear Fluid Pharmacokinetics Following Oral Prednisone Administration in Dogs With and Without Conjunctivitis
  192. Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non‐Small Cell Lung Cancer
  193. Derivation of adult canine intestinal organoids for translational research in gastroenterology
  194. CAR T Cell Immunotherapy in Human and Veterinary Oncology: Changing the Odds Against Hematological Malignancies
  195. A Review of Relevant Therapeutic Targets for the Management of Congestive Heart Failure in Dogs: Present and Future Directions
  196. Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non-Small Cell Lung Cancer
  197. Sacubitril/valsartan (LCZ696) significantly reduces aldosterone and increases cGMP circulating levels in a canine model of RAAS activation
  198. The Role of the Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review
  199. Pharmacokinetics of Ertapenem in Sheep (Ovis aries) with Experimentally Induced Urinary Tract Infection
  200. Workshop Report: USP Workshop on Exploring the Science of Drug Absorption
  201. Population Modeling of Tumor Growth Curves, the Reduced Gompertz Model and Prediction of the Age of a Tumor
  202. Correlating Gastrointestinal Histopathologic Changes to Clinical Disease Activity in Dogs With Idiopathic Inflammatory Bowel Disease
  203. CAR T-Cell Immunotherapy in Human and Veterinary Oncology: Changing the Odds against Hematological Malignancies
  204. Relative Oral Bioavailability of Two Amoxicillin–Clavulanic Acid Formulations in Healthy Dogs: A Pilot Study
  205. Clinical features of cats with aqueous tear deficiency: a retrospective case series of 10 patients (17 eyes)
  206. Adult Canine Intestinal Derived Organoids: A Novel In Vitro System for Translational Research in Comparative Gastroenterology
  207. Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogs
  208. Sacubitril/valsartan (LCZ696) Significantly Reduces Aldosterone and Increases cGMP Circulating Levels in a Canine Model of RAAS Activation
  209. Comparative plasma and interstitial fluid pharmacokinetics and tissue residues of ceftiofur crystalline-free acid in cattle with induced coliform mastitis
  210. Adverse reactions to fentanyl transdermal patches in calves: a preliminary clinical and pharmacokinetic study
  211. Impact of Flow Rate, Collection Devices, and Extraction Methods on Tear Concentrations Following Oral Administration of Doxycycline in Dogs and Cats
  212. Population variability in animal health: Influence on dose-exposure-response relationships: Part II: Modelling and simulation
  213. Effects of short-term anti-inflammatory glucocorticoid treatment on clinicopathologic, echocardiographic, and hemodynamic variables in systemically healthy dogs
  214. Pharmacokinetics of fentanyl citrate and norfentanyl in Holstein calves and effect of analytical performances on fentanyl parameter estimation
  215. Effect of tear collection on lacrimal total protein content in dogs and cats: a comparison between Schirmer strips and ophthalmic sponges
  216. Comparison of milk and plasma pharmacokinetics of meloxicam in postpartum versus mid-lactation Holstein cows
  217. Network on veterinary medicines initiated by the European Federation For Pharmaceutical Sciences
  218. Intestinal Stem Cells to Advance Drug Development, Precision, and Regenerative Medicine: A Paradigm Shift in Translational Research
  219. Mathematical modeling and simulation in animal health. Part III: Using nonlinear mixed-effects to characterize and quantify variability in drug pharmacokinetics
  220. Model-Based Reverse Translation Between Veterinary and Human Medicine: The One Health Initiative
  221. Tear fluid collection in dogs and cats using ophthalmic sponges
  222. Modeling of Large Pharmacokinetic Data Using Nonlinear Mixed-Effects: A Paradigm Shift in Veterinary Pharmacology. A Case Study With Robenacoxib in Cats
  223. Position Paper: EUFEPS Network on Veterinary Medicines Initiative
  224. Multiple comparison procedure and modeling: a versatile tool for evaluating dose-response relationships in veterinary pharmacology - a case study with furosemide
  225. Mathematical modeling and simulation in animal health - Part II: principles, methods, applications, and value of physiologically based pharmacokinetic modeling in veterinary medicine and food safety assessment
  226. Mathematical modeling and simulation in animal health. Part I: Moving beyond pharmacokinetics
  227. Chronobiology and Pharmacologic Modulation of the Renin–Angiotensin–Aldosterone System in Dogs: What Have We Learned?
  228. Pharmacokinetic/Pharmacodynamic Modeling of Renin-Angiotensin Aldosterone Biomarkers Following Angiotensin-Converting Enzyme (ACE) Inhibition Therapy with Benazepril in Dogs
  229. FIRST-IN-CLASS ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR LCZ696 MODULATES THE DYNAMICS OF THE RENIN CASCADE AND NATRIURETIC PEPTIDES SYSTEM WITH SIGNIFICANT REDUCTION OF ALDOSTERONE EXPOSURE
  230. Influence of feeding schedules on the chronobiology of renin activity, urinary electrolytes and blood pressure in dogs
  231. Population pharmacokinetic analysis of blood concentrations of robenacoxib in dogs with osteoarthritis
  232. Chronobiology of the renin-angiotensin-aldosterone system in dogs: relation to blood pressure and renal physiology
  233. Animal Health Modeling & Simulation Society: a new society promoting model-based approaches in veterinary pharmacology
  234. Response to letter from Atkinset al. Capturing the dynamics of systemic Renin‐Angiotensin‐Aldosterone System (RAAS) peptides heightens the understanding of the effect of benazepril in dogs
  235. Capturing the dynamics of systemic Renin-Angiotensin-Aldosterone System (RAAS) peptides heightens the understanding of the effect of benazepril in dogs